Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Thanks Go horns, larscot, sge1.....Awaiting further input, additions corrections

Even if mutuals could be persuaded to breach their investment regulations, a $2bn valuation doesn't appear realistic. Reduce the o/s to under 100,000,000 and $5 per share is achievable/sustainable.

 

 

Be well

Share
New Message
Please login to post a reply